Clinical trial
Pharmacokinetics and Safety of Ertapenem in the Postpartum Period
NCT01587495 is registered in ClinicalTrials.gov with Daniel Benjamin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetics and Safety of Ertapenem in the Postpartum Period
- Lead sponsor
- Daniel Benjamin
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- March 31, 2012
- Completion date
- January 31, 2014
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.